SGLT

15 Item(s)

per page

Set Descending Direction
  1. Dapagliflozin (BMS512148)

    Catalog No. A10285
    Quick View
    SGLT2 inhibitor
    Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Learn More
  2. Canagliflozin

    Catalog No. A11100
    Quick View
    SGLT2 Inhibitor
    Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2). Learn More
  3. EGT1442

    Catalog No. A10155
    Quick View
    SGLT2 inhibitor
    EGT1442 is a potent and selective SGLT2 inhibitor. Learn More
  4. Empagliflozin

    Catalog No. A12440
    Quick View
    Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes. Learn More
  5. LX-4211

    Catalog No. A12680
    Quick View
    SGLT Inhibitor‎
    LX4211 is a Dual SGLT1/SGLT2 Inhibitor Learn More
  6. Tofogliflozin

    Catalog No. A12690
    Quick View
    SGLT2 inhibitor
    Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Learn More
  7. Remogliflozin

    Catalog No. A13971
    Quick View
    SGLT2 inhibitor
    Remogliflozin inhibits the sodium-glucose transport (SGLT2) proteins, which are responsible for glucose reabsorption in the kidney. Learn More
  8. Ipragliflozin

    Catalog No. A13556
    Quick View
    SGLT2 inhibitor
    Ipragliflozin is a highly potent and selective SGLT2 inhibitor with IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6. Learn More
  9. Luseogliflozin

    Catalog No. A13476
    Quick View
    SGLT2 Inhibitor
    Luseogliflozin is an orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor developed by Taisho Pharmaceutical for the treatment of patients with type 2 diabetes mellitus (T2DM). Learn More
  10. T-1095

    Catalog No. A15463
    Quick View
    Na+-glucose transporter inhibitor
    T-1095 is a potent and selective inhibitor of Na+-glucose cotransporters (SGLTs). Learn More
  11. Canagliflozin hemihydrate

    Catalog No. A16817
    Quick View
    SGLT2 inhibitor
    Canagliflozin hemihydrate is the hemihydrate form of canagliflozin, which is a SGLT2 inhibitor with IC50 of 2.2 nM for hSGLT2 in a cell-free assay, exhibits 413-fold selectivity over hSGLT1. Learn More
  12. Ertugliflozin L-pyroglutamic acid

    Catalog No. A18054
    Quick View
    SGLT inhibitor
    Ertugliflozin pidolate belongs to the class of potent and selective inhibitors of the sodium-dependent glucose cotransporters (SGLT), more specifically the type 2 which is responsible for about 90% of the glucose reabsorption from glomerulus. Learn More
  13. SGL5213

    Catalog No. A18723
    Quick View
    SGLT1 inhibitor
    SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. Learn More
  14. Dapagliflozin impurity

    Catalog No. A19103
    Quick View
    SGLT2 inhibitor
    Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor. Learn More
  15. Licogliflozin

    Catalog No. A12828
    Quick View
    SGLT1/SGLT2 inhibitor
    Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor. Learn More

15 Item(s)

per page

Set Descending Direction
Rewards